| Identification | Back Directory | [Name]
5H-Indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6H)-dione, 12-(4-deoxy-4-fluoro-β-D-glucopyranosyl)-3,9-difluoro-12,13-dihydro- | [CAS]
406913-72-2 | [Synonyms]
BMS250749
BMS-250749
BMS 250749
5H-Indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6H)-dione, 12-(4-deoxy-4-fluoro-β-D-glucopyranosyl)-3,9-difluoro-12,13-dihydro- | [Molecular Formula]
C26H18F3N3O6 | [MOL File]
406913-72-2.mol | [Molecular Weight]
525.44 |
| Hazard Information | Back Directory | [Uses]
BMS-250749 is a topoisomerase I (Top I) inhibitor of the fluoroglycosyl-3,9-difluoroindolecarbazole class. BMS-250749 exhibits potent cytotoxicity and selectivity, and shows curative antitumor activity against Lewis lung cancer. BMS-250749 exhibits broad-spectrum antitumor activity superior to CPT-11 in certain preclinical xenograft models.[1]. | [References]
[1] Discovery of a Fluoroindolo[2,3-a]carbazole Clinical Candidate with Broad Spectrum Antitumor Activity in Preclinical Tumor Models Superior to the Marketed Oncology Drug, CPT-11 |
|
|